[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021; 71, 209−49. doi:  10.3322/caac.21660
[2] Chen B, Wu JX, Cheng SH, et al. Phase 2 study of adjuvant radiotherapy following narrow-margin hepatectomy in patients with HCC. Hepatology, 2021; 74, 2595−604. doi:  10.1002/hep.31993
[3] Tian Y, Gong GY, Ma LL, et al. Anti-cancer effects of Polyphyllin I: An update in 5 years. Chem Biol Interact, 2020; 316, 108936. doi:  10.1016/j.cbi.2019.108936
[4] Liu JZ, Liu YZ, Li HC, et al. Polyphyllin D induces apoptosis and protective autophagy in breast cancer cells through JNK1-Bcl-2 pathway. J Ethnopharmacol, 2022; 282, 114591. doi:  10.1016/j.jep.2021.114591
[5] Bisteau X, Caldez MJ, Kaldis P. The complex relationship between liver cancer and the cell cycle: A story of multiple regulations. Cancers, 2014; 6, 79−111. doi:  10.3390/cancers6010079
[6] Badal S, Delgoda R. Role of the modulation of CYP1A1 expression and activity in chemoprevention. J Appl Toxicol, 2014; 34, 743−53. doi:  10.1002/jat.2968
[7] Suski JM, Braun M, Strmiska V, et al. Targeting cell-cycle machinery in cancer. Cancer Cell, 2021; 39, 759−78. doi:  10.1016/j.ccell.2021.03.010
[8] Lasunción MA, Martínez-Botas J, Martín-Sánchez C, et al. Cell cycle dependence on the mevalonate pathway: Role of cholesterol and non-sterol isoprenoids. Biochem Pharmacol, 2022; 196, 114623. doi:  10.1016/j.bcp.2021.114623
[9] Nakakuki M, Shimano H, Inoue N, et al. A transcription factor of lipid synthesis, sterol regulatory element-binding protein (SREBP)-1a causes G1 cell-cycle arrest after accumulation of cyclin-dependent kinase (cdk) inhibitors. FEBS J, 2007; 274, 4440−52. doi:  10.1111/j.1742-4658.2007.05973.x
[10] Liu YX, Hua WW, Li Y, et al. Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP/SREBP-1 signaling pathway-mediated lipogenesis. Biochem Pharmacol, 2020; 174, 113776. doi:  10.1016/j.bcp.2019.113776